Ginkgo Bioworks Holdings, Inc.
GPTKB entity
Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Agenome (2021)
Biosyntia (2021) Ecovative Design (2021) Genomatica (2021) Synlogic (2020) Tessera Therapeutics (2021) Zymergen (2021) |
| gptkbp:ceo |
gptkb:Jason_Kelly
|
| gptkbp:client |
Major food and beverage companies
|
| gptkbp:collaboration |
Biopharmaceutical companies
|
| gptkbp:collaborator |
gptkb:Harvard_University
|
| gptkbp:employees |
500+
|
| gptkbp:focus |
Synthetic biology
|
| gptkbp:focus_area |
Agricultural biotechnology
Environmental biotechnology Food biotechnology Pharmaceutical biotechnology Industrial biotechnology |
| gptkbp:founded |
gptkb:2008
|
| gptkbp:founder |
gptkb:Jason_Kelly
|
| gptkbp:goal |
Sustainable production of chemicals.
|
| gptkbp:headquarters |
gptkb:Boston,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ginkgo Bioworks Holdings, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:innovation |
Genetic engineering
|
| gptkbp:investment |
Series D
Series E SPAC merger $425 million (2021) |
| gptkbp:ipo |
September 2021
|
| gptkbp:is_a_platform_for |
gptkb:Ginkgo_Cloud
Ginkgo Biosecurity Ginkgo Bioworks Platform Ginkgo Foundry |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
Synthetic biology market
|
| gptkbp:mission |
To make biology easier to engineer.
|
| gptkbp:partnership |
Various pharmaceutical companies
Biotechnology firms |
| gptkbp:product |
Custom microbes
|
| gptkbp:project |
COVID-19 testing solutions
|
| gptkbp:research |
Microbial consortia
|
| gptkbp:revenue |
$100 million (2020)
|
| gptkbp:service |
Biomanufacturing
|
| gptkbp:services |
Organism engineering
|
| gptkbp:stock_symbol |
gptkb:DNA
|
| gptkbp:subsidiary |
Ginkgo Bioworks, Inc.
|
| gptkbp:technology |
Cell programming
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
www.ginkgobioworks.com
|
| gptkbp:bfsParent |
gptkb:Ginkgo_Bioworks
|
| gptkbp:bfsLayer |
4
|